TRAIL-R: A Potential Drug Target and Biomarker for Cancer and Autoimmune Diseases

Target Name: Tumor Necrosis Factor Receptor Superfamily Member 10 (TRAIL-R)

NCBI ID: P38440

Other Name(s): Tumor Necrosis Factor Receptor Superfamily Member 10 | TNF-related apoptosis-inducing ligand receptor | Death receptor | TRAIL-R | TRAIL receptor

TRAIL-R: A Potential Drug Target and Biomarker for Cancer and Autoimmune Diseases

Tumor Necrosis Factor Receptor Superfamily Member 10 (TRAIL-R) is a protein that is expressed in a variety of tissues throughout the body, including the liver, spleen, thymus, and pancreas. It is a member of the Tumor Necrosis Factor Receptor Superfamily, which is a family of cytokines that play a crucial role in the immune response and tissue repair.

TRAIL-R is a 21-kDa protein that is composed of a single transmembrane domain and a cytoplasmic tail. It has been shown to play a role in a variety of cellular processes, including inflammation, autophagy, and cell death.

One of the most promising aspects of TRAIL-R is its potential as a drug target. Because TRAIL-R is involved in a wide range of cellular processes that are important for human health, it is an attractive target for the development of new treatments for a variety of diseases.

One of the ways that TRAIL-R is being targeted for drug development is through its role in cancer. Cancer is a leading cause of death in the world, and there is a strong need for new treatments that can effectively target cancer cells. TRAIL-R has been shown to be involved in the regulation of cancer cell growth and survival, and it is possible that it could be used as a drug to inhibit the growth of cancer cells.

Another potential use for TRAIL-R is its role in autoimmune diseases. Autoimmune diseases are a group of conditions in which the immune system attacks the body's own tissues, leading to inflammation and damage. TRAIL-R is involved in the regulation of the immune response, and it is possible that it could be used as a drug to treat autoimmune diseases.

In addition to its potential uses in cancer and autoimmune diseases, TRAIL-R is also being studied for its potential as a biomarker. Tumor necrosis factor receptor superfamily member 10 is a protein that is expressed in a variety of tissues throughout the body, including the liver, spleen, thymus, and pancreas. Therefore, it is possible that TRAIL-R could be used as a biomarker for a variety of diseases, including cancer and autoimmune diseases.

Overall, Tumor Necrosis Factor Receptor Superfamily Member 10 (TRAIL-R) is a protein that is expressed in a variety of tissues throughout the body and is involved in a wide range of cellular processes. Its potential as a drug target and biomarker make it an attractive target for further research and development.

Protein Name: Tumor Necrosis Factor Receptor Superfamily Member 10 (TRAIL-R) (nonspecified Subtype)

More Common Targets